FDA extends deadline for nitrosamine testing submissions
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)ComplianceGenericsManufacturingNitrosaminesPharmaceuticalsQuality Assurance and ControlRegulatory strategyUnited States